3rd Quarter - Report

ARENTFOX SCHIFF LLP for TRANSPARENCY RISING CORP.

Period 3rd Quarter 2026 Filed Oct 19, 2026 Signed by Randall A. Brater

Official filing
Firm
ARENTFOX SCHIFF LLP
Client
TRANSPARENCY RISING CORP.
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices H.R. 7148 (Consolidated Appropriations Act, 2026), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices H.R. 6609 and H.R. 6610 (Pharmacists Fight Back Act), generally H.R. 5582 and S. 2355 (Patients Deserve Price Tags Act), generally

LobbyistCovered position, as disclosed
PHILIP ENGLISH —
KATHERINE KRAMER —
DANIEL SJOSTEDT —
BLAKE THELANDER —

Contacted: HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Office of Management & Budget (OMB)

Bills named: H.R. 6610 (119th), S. 2355 (119th), H.R. 6609 (119th), H.R. 7148 (119th), H.R. 5582 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.